AU2676397A - Methods for treating middle and inner ear disorders - Google Patents

Methods for treating middle and inner ear disorders

Info

Publication number
AU2676397A
AU2676397A AU26763/97A AU2676397A AU2676397A AU 2676397 A AU2676397 A AU 2676397A AU 26763/97 A AU26763/97 A AU 26763/97A AU 2676397 A AU2676397 A AU 2676397A AU 2676397 A AU2676397 A AU 2676397A
Authority
AU
Australia
Prior art keywords
methods
inner ear
ear disorders
treating middle
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26763/97A
Inventor
Michael J. Hart
Mark C Manning
Eli Shefter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Technology Corp
Original Assignee
University of Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Technology Corp filed Critical University of Technology Corp
Publication of AU2676397A publication Critical patent/AU2676397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
AU26763/97A 1996-04-18 1997-04-18 Methods for treating middle and inner ear disorders Abandoned AU2676397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1557296P 1996-04-18 1996-04-18
US60015572 1996-04-18
PCT/US1997/006507 WO1997038698A1 (en) 1996-04-18 1997-04-18 Methods for treating middle and inner ear disorders

Publications (1)

Publication Number Publication Date
AU2676397A true AU2676397A (en) 1997-11-07

Family

ID=21772209

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26763/97A Abandoned AU2676397A (en) 1996-04-18 1997-04-18 Methods for treating middle and inner ear disorders

Country Status (2)

Country Link
AU (1) AU2676397A (en)
WO (1) WO1997038698A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047543A2 (en) * 1998-03-18 1999-09-23 University Technology Corporation Sustained-release composition including amorphous polymer
US8197461B1 (en) * 1998-12-04 2012-06-12 Durect Corporation Controlled release system for delivering therapeutic agents into the inner ear
IS6390A (en) 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Experiences of antibiotic coating of carcasses containing microspheres, thus coated carcasses and also of their use
IS6389A (en) 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Experiences of antibiotic coating of carcasses containing microspheres, and also of such coated carcasses and their use
US9072662B2 (en) 2004-03-29 2015-07-07 Auris Medical Ag Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US20060063802A1 (en) 2004-03-29 2006-03-23 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US8268866B2 (en) 2004-03-29 2012-09-18 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
DE102005004343A1 (en) * 2005-01-25 2006-08-10 Eberhard-Karls-Universität Tübingen Universitätsklinikum Treatment of phantom phenomena
EA017264B1 (en) 2005-09-28 2012-11-30 Аурис Медикаль Аг Use of arylcycloalkylamide composition for preparing a medicament for the treatment of inner ear disorder
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
RU2499592C2 (en) 2008-04-21 2013-11-27 Отономи, Инк. Pharmaceutical composition for treating ear diseases
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
MY161021A (en) 2008-05-14 2017-03-31 Otonomy Inc Controlled release corticosteroid and methods for the treatment of otic disorders
US8648119B2 (en) 2008-05-23 2014-02-11 Otonomy, Inc. Controlled release immunomodulator compositions and methods for the treatment of otic disorders
RU2513142C2 (en) 2008-06-12 2014-04-20 Медтроник Ксомед Инк. Method of treating chronic wounds
US8846770B2 (en) 2008-06-18 2014-09-30 Otonomy, Inc. Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
WO2010011466A2 (en) 2008-06-27 2010-01-28 Otonomy, Inc. Controlled-release cns modulating compositions and methods for the treatment of otic disorders
US8349353B2 (en) 2008-06-27 2013-01-08 Otonomy, Inc. Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
US8784870B2 (en) 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
JP5421366B2 (en) 2008-07-21 2014-02-19 オトノミ―，インク． Controlled release otic structure modulating and innate immune system modulating compounds and methods for treatment of otic disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US8399018B2 (en) 2008-07-21 2013-03-19 Otonomy, Inc. Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
US20100016450A1 (en) * 2008-07-21 2010-01-21 Otonomy, Inc. Controlled release delivery devices for the treatment of otic disorders
US8496957B2 (en) 2008-07-21 2013-07-30 Otonomy, Inc Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
WO2010048095A2 (en) 2008-10-22 2010-04-29 House Ear Institute Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor
ES2862673T3 (en) 2011-12-12 2021-10-07 Zilentin AG Treatment of tinnitus by modulating the NKCC1 chloride cotransporter in the auditory system
MX2016002408A (en) 2013-08-27 2016-10-28 Otonomy Inc Treatment of pediatric otic disorders.
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
WO1997038698A1 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
AU2676397A (en) Methods for treating middle and inner ear disorders
AU4059897A (en) Kinesiologic mouthpiece and method
AU3552195A (en) Improved patient-transport and treatment apparatus
AU2543097A (en) Method for treating pain
AU2587297A (en) Method for treating pain
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU2035195A (en) Electroheating apparatus and methods
AU5447998A (en) Apparatus and methods for analyzing body sounds
AU4052897A (en) Cancer treatment method
AU5439996A (en) Compositions and methods for treating pain
AU1007797A (en) Trackable earplug
AU4261697A (en) Compounds and methods
AU5453798A (en) Inner ear diagnostic apparatus and method
AU2058697A (en) Treatment of sleep disorders
AU7297998A (en) Bariatric treatment system and relating methods
AU1697197A (en) Immunoconjugate for the treatment of aids
AU2340897A (en) Method for treating pain
AU5298699A (en) Dnazymes and methods for treating hpv-related disorders
AU3660097A (en) Biomedical electrode and method for its manufacture
AU1926597A (en) Treatment of cocoa
AU5224998A (en) Hair-curler and method for setting hair
AU4910797A (en) Coated ophthalmic and implantable devices and methods for producing same
AU4027097A (en) Method of treatment
AU4584797A (en) Ocular implants and methods for their manufacture
AU1818497A (en) Arrangement and method for communication